TerrAscend Corp.
TSX:TSND.TODrug Manufacturers - Specialty & Generic
Healthcare
$0.52 -1.61%
-$0.02 today
- Market cap
- $193.65M
- Beta
- 2.04
- P/E (TTM)
- -2.5
- EPS (TTM)
- -$0.26
52W Low $0.33High $2.00
Volume 0.26M
Average 0.31M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
$22.07M
FY 2025 · Annual
-41.8% YoYInvesting Cash Flow
-$15.03M
FY 2025 · Annual
Financing Cash Flow
$4.26M
FY 2025 · Annual
Cash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (21.82M) | 22.61M | (27.63M) | (72.67M) | (24.49M) |
| Depreciation & Amortization | 13.63M | 23.87M | 30.64M | 22.99M | 17.51M |
| Deferred Income Tax | (1.81M) | (46.02M) | (18.92M) | (8.75M) | (532K) |
| Stock-Based Compensation | 14.93M | 12.18M | 7.71M | 9.71M | 5.01M |
| Change in Working Capital | (45.17M) | 37.81K | 35.67M | 28.84M | 23.24M |
| Accounts Receivables | (4.02M) | 3.73M | (12.5M) | (2.95M) | 1.67M |
| Inventory | (23.19M) | 881.27K | (7M) | 4.17M | 6.05M |
| Accounts Payables | 3.53M | (15.78M) | 869.2K | (5.29M) | (4.59M) |
| Other Working Capital | (21.49M) | 11.2M | 52.07M | 32.91M | 20.11M |
| Other Non-Cash Items | (4.62K) | (38.8M) | (2.42K) | 57.84M | 1.34M |
| Operating Cash Flow | (38.43M) | (33.38M) | 27.47M | 37.95M | 22.07M |
| Capital Expenditures | (50.39M) | (54.61M) | (9.43M) | (10.55M) | (8.76M) |
| Acquisitions (Net) | (53.55M) | 19.77M | (16.79M) | (250K) | (8.68M) |
| Purchases of Investments | (62.65M) | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 34.17M | 7.27M | 5.44M | (2.64M) | 3.16M |
| Investing Cash Flow | (132.42M) | (27.58M) | (16.22M) | (12.25M) | (15.03M) |
| Debt Repayment | (3.67M) | 54.4K | (27.76M) | (17.18M) | 8.36M |
| Common Stock Issued | 200.83M | 23.62M | 20.82M | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | (215K) | (417.18K) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (14.96M) | (19.95M) | (5.56M) | (7.32M) | (3.69M) |
| Financing Cash Flow | 182.2M | 3.72M | (12.5M) | (24.72M) | 4.26M |
| Effect of Forex Changes | 2.45M | (2.9M) | (168K) | 653K | (2.11M) |
| Net Change in Cash | 20.42M | (52.88M) | (1.42M) | 1.64M | 9.19M |
| Free Cash Flow | (88.82M) | (88M) | 18.04M | 27.4M | 13.31M |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$24.5M
+ D&A$17.5M
+ Stock-Based Comp$5.0M
- Deferred Tax-$532.0K
+ Working Capital$23.2M
+ Other Non-Cash$1.3M
= Operating Cash Flow$22.1M
- Capex-$8.8M
= Free Cash Flow$13.3M
Analysis
FY2025 free cash flow is $13.3M. FCF conversion is -54.3% of net income. Operating cash flow was $22.1M, with capex of -$8.8M. The largest bridge item is Working Capital at $23.2M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
No filings found.
Does TSND.TO generate free cash flow?
TerrAscend Corp. (TSND.TO) generated $13.31M of free cash flow in fiscal 2025.
How much operating cash flow does TSND.TO produce?
Operating cash flow was $22.07M, before capital expenditures of $8.76M.
Continue the stock analysis
Jump to another research area for this company.